CORRECTION article

Front. Cell Dev. Biol., 24 August 2022

Sec. Cell Death and Survival

Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.999965

Corrigendum: Butyric acid protects against renal ischemia–reperfusion injury by adjusting the Treg/Th17 balance via HO-1/p-STAT3 signaling

    ZC

    Zhen Chen 1

    MW

    Miaomiao Wang 1

    SY

    Shikun Yang 2

    JS

    Jian Shi 1

    TJ

    Tianhao Ji 2

    WD

    Wei Ding 1,3

    LJ

    Lianghua Jiang 4

    ZF

    Zhiwen Fan 5*

    JC

    Jing Chen 1*

    YL

    Yunjie Lu 1*

  • 1. The Third Affiliated Hospital of Soochow University, Changzhou, China

  • 2. Key Laboratory of Liver Transplantation, Hepatobiliary/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Chinese Academy of Medical Sciences, Nanjing, China

  • 3. Wujin Hospital Affiliated With Jiangsu University, Changzhou, China

  • 4. The First People’s Hospital of Kunshan, Kunshan, China

  • 5. Department of Pathology, Affiliated Nanjing Drum Tower Hospital of Nanjing University School of Medicine, Nanjing, China

Article metrics

View details

1

Citations

1,2k

Views

704

Downloads

In the published article, there was an error in Figure 4H as published. We applied the incorrect picture to Figure 4H. The corrected Figure 4H and its caption “IRI + BA + BRL52537” appear below.

FIGURE 4

FIGURE 4

BA protects against renal IRI via p-STAT3/SOCS3 signaling. (A,B) BA treatments attenuated the expression of p-STAT3 but not p-JAK2. (C,D) After BRL52537 treatment, the expression of p-STAT3 but not p-JAK2 was increased. (E–G) BRL52537 significantly attenuated the anti-inflammatory effects of BA on renal IRI. (H) HE staining indicated that BRL52537 significantly attenuated the protective effects of BA on renal IRI. Sample size = 3 in each group. Data were presented as mean ± standard deviation. N.S. p > 0.05, *p < 0.05, **p < 0.01.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

butyric acid, renal ischemia–reperfusion injury, Treg, Th17, HO-1, STAT3

Citation

Chen Z, Wang M, Yang S, Shi J, Ji T, Ding W, Jiang L, Fan Z, Chen J and Lu Y (2022) Corrigendum: Butyric acid protects against renal ischemia–reperfusion injury by adjusting the Treg/Th17 balance via HO-1/p-STAT3 signaling. Front. Cell Dev. Biol. 10:999965. doi: 10.3389/fcell.2022.999965

Received

22 July 2022

Accepted

22 July 2022

Published

24 August 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2022

Updates

Copyright

*Correspondence: Yunjie Lu, ; Jing Chen, ; Zhiwen Fan,

†These authors have contributed equally to this work and share first authorship

This article was submitted to Cell Death and Survival, a section of the journal Frontiers in Cell and Developmental Biology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics